Abu Sin Muna, Nahrgang Saskia, Ziegelmann Antina, Clarici Alexandra, Matz Sibylle, Tenhagen Bernd-Alois, Eckmanns Tim
Abteilung für Infektionsepidemiologie, Robert Koch-Institut, Seestraße 10, 13353, Berlin, Deutschland.
Regionalbüro für Europa, Weltgesundheitsorganisation (WHO), Kopenhagen, Dänemark.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 May;61(5):507-514. doi: 10.1007/s00103-018-2722-2.
Antimicrobial resistance (AMR) is increasingly perceived as a global health problem. To tackle AMR effectively, a multisectoral one health approach is needed. We present some of the initiatives and activities at the national and global level that target the AMR challenge. The Global Action Plan on AMR, which has been developed by the World Health Organization (WHO), in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (OIE) is considered a blueprint to combat AMR. Member states endorsed the action plan during the World Health Assembly 2015 and committed themselves to develop national action plans on AMR. The German Antibiotic Resistance Strategy (DART 2020) is based on the main objectives of the global action plan and was revised and published in 2015. Several examples of the implementation of DART 2020 are outlined here.
抗菌药物耐药性（AMR）日益被视为一个全球健康问题。为有效应对AMR，需要采取多部门的“同一健康”方法。我们介绍了国家和全球层面针对AMR挑战的一些举措和活动。由世界卫生组织（WHO）与联合国粮食及农业组织（FAO）和世界动物卫生组织（OIE）密切合作制定的《全球抗菌药物耐药性行动计划》被视为应对AMR的蓝图。成员国在2015年世界卫生大会期间批准了该行动计划，并承诺制定国家抗菌药物耐药性行动计划。《德国抗菌药物耐药性战略（2020年）》基于全球行动计划的主要目标，并于2015年进行了修订和发布。本文概述了《德国抗菌药物耐药性战略（2020年）》的几个实施实例。
